Literature DB >> 33416449

Donor-specific phenotypic variation in hiPSC cardiomyocyte-derived exosomes impacts endothelial cell function.

Amy Turner1, Praful Aggarwal1, Andrea Matter1, Benjamin Olson1,2, C Charles Gu3, Steven C Hunt4,5, Cora E Lewis6, Donna K Arnett7, Rachel Lorier1, Ulrich Broeckel1.   

Abstract

Exosomes are an important mechanism of cell-cell interaction in the cardiovascular system, both in maintaining homeostasis and in stress response. Interindividual differences that alter content in exosomes may play a role in cardiovascular disease pathology. To study the effect of interindividual cardiomyocyte (CM) variation, we characterized exosomal content in phenotypically diverse human induced pluripotent stem cell-derived CMs (hiPSC-CMs). Cell lines were generated from six participants in the HyperGEN cohort: three with left ventricular hypertrophy (LVH) and three with normal left ventricular mass (LVM). Sequence analysis of the intracellular and exosomal RNA populations showed distinct expression pattern differences between hiPSC-CM lines derived from individuals with LVH and those with normal LVM. Functional analysis of hiPSC-endothelial cells (hiPSC-ECs) treated with exosomes from both hiPSC-CM groups showed significant variation in response, including differences in tube formation, migration, and proliferation. Overall, treatment of hiPSC-ECs with exosomes resulted in significant expression changes associated with angiogenesis and endothelial cell vasculogenesis. However, the hiPSC-ECs treated with exosomes from the LVH-affected donors exhibited significantly increased proliferation but decreased tube formation and migration, suggesting angiogenic dysregulation.NEW & NOTEWORTHY The intracellular RNA and the miRNA content in exosomes are significantly different in hiPSC-CMs derived from LVH-affected individuals compared with those from unaffected individuals. Treatment of endothelial cells with these exosomes functionally affects cellular phenotypes in a donor-specific manner. These findings provide novel insight into underlying mechanisms of hypertrophic cell signaling between different cell types. With a growing interest in stem cells and exosomes for cardiovascular therapeutic use, this also provides information important for regenerative medicine.

Entities:  

Keywords:  cardiomyocyte hypertrophy; exosomes; human induced pluripotent stem cells; intercellular communication; miRNA

Mesh:

Substances:

Year:  2021        PMID: 33416449      PMCID: PMC8294700          DOI: 10.1152/ajpheart.00463.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  65 in total

Review 1.  Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.

Authors:  Ji-Hye Jung; Xuebin Fu; Phillip C Yang
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

Review 2.  Concise Review: MSC-Derived Exosomes for Cell-Free Therapy.

Authors:  Donald G Phinney; Mark F Pittenger
Journal:  Stem Cells       Date:  2017-03-10       Impact factor: 6.277

Review 3.  Exosomes and exosomal miRNAs in cardiovascular protection and repair.

Authors:  Costanza Emanueli; Andrew I U Shearn; Gianni D Angelini; Susmita Sahoo
Journal:  Vascul Pharmacol       Date:  2015-04-11       Impact factor: 5.773

4.  Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.

Authors:  Florian Custodis; Marcel Eberl; Heiko Kilter; Michael Böhm; Ulrich Laufs
Journal:  Cardiovasc Res       Date:  2006-04-19       Impact factor: 10.787

5.  Cardiac growth and angiogenesis coordinated by intertissue interactions.

Authors:  Kenneth Walsh; Ichiro Shiojima
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

Review 6.  ROS signalling between endothelial cells and cardiac cells.

Authors:  Min Zhang; Ajay M Shah
Journal:  Cardiovasc Res       Date:  2014-03-03       Impact factor: 10.787

7.  Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.

Authors:  Xu Sun; Xiaotang Ma; Jinju Wang; Yuhui Zhao; Yue Wang; Ji C Bihl; Yanfang Chen; Chuanlu Jiang
Journal:  Oncotarget       Date:  2017-05-30

Review 8.  Expert consensus document: Mitochondrial function as a therapeutic target in heart failure.

Authors:  David A Brown; Justin B Perry; Mitchell E Allen; Hani N Sabbah; Brian L Stauffer; Saame Raza Shaikh; John G F Cleland; Wilson S Colucci; Javed Butler; Adriaan A Voors; Stefan D Anker; Bertram Pitt; Burkert Pieske; Gerasimos Filippatos; Stephen J Greene; Mihai Gheorghiade
Journal:  Nat Rev Cardiol       Date:  2016-12-22       Impact factor: 32.419

9.  Signalling in sarcomeres in development and disease.

Authors:  W van Eldik; R Passier
Journal:  Neth Heart J       Date:  2013-07       Impact factor: 2.380

10.  N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.

Authors:  Hongsheng Wang; Qianqian Deng; Ziyan Lv; Yuyi Ling; Xue Hou; Zhuojia Chen; Xiaoxiao Dinglin; Shuxiang Ma; Delan Li; Yingmin Wu; Yanxi Peng; Hongbing Huang; Likun Chen
Journal:  Mol Cancer       Date:  2019-12-10       Impact factor: 27.401

View more
  2 in total

1.  Hypoxic Conditions Promote the Angiogenic Potential of Human Induced Pluripotent Stem Cell-Derived Extracellular Vesicles.

Authors:  André Cronemberger Andrade; Martin Wolf; Heide-Marie Binder; Fausto Gueths Gomes; Felix Manstein; Patricia Ebner-Peking; Rodolphe Poupardin; Robert Zweigerdt; Katharina Schallmoser; Dirk Strunk
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

2.  Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.

Authors:  Xuehui Fan; Lukas Cyganek; Katja Nitschke; Stefanie Uhlig; Philipp Nuhn; Karen Bieback; Daniel Duerschmied; Ibrahim El-Battrawy; Xiaobo Zhou; Ibrahim Akin
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.